Management & ScienceAndere

2023

Schoffer O, Schriefer D, Werblow A, Gottschalk A, Peschel P, Liang LA, Karmann A, Klug SJ.

BMC Health Serv Res. 2023 Oct 11;23(1):1081.

Multiple SkleroseMS Behandlung

2023

Naismith RT, Wolinsky JS, Wundes A, LaGanke C, Arnold DL, Obradovic D, Freedman MS, Gudesblatt M, Ziemssen T, Kandinov B, Bidollari I, Lopez-Bresnahan M, Nangia N, Rezendes D, Yang L, Chen H, Liu S, Hanna J, Miller C, Leigh-Pemberton R.

Mult Scler. 2020 Nov;26(13):1729-1739. doi: 10.1177/1352458519881761.

Multiple SkleroseMS Behandlung

2023

Bayas A, Berthele A, Blank N, Dreger P, Faissner S, Friese MA, Gerdes LA, Grauer OM, Häussler V, Heesen C, Janson D, Korporal-Kuhnke M, Kowarik M, Kröger N, Lünemann JD, Martin R, Meier U, Meuth S, Muraro P, Platten M, Schirmer L, Stürner KH, Stellmann JP, Scheid C, Bergh FT, Warnke C, Wildemann B, Ziemssen T.

Ther Adv Neurol Disord. 2023 Sep 28;16:17562864231180730.

Multiple SkleroseMS Behandlung

2023

Coles AJ, Achiron A, Traboulsee A, Singer BA, Pozzilli C, Oreja-Guevara C, Giovannoni G, Comi G, Freedman MS, Ziemssen T, Shiota D, Rawlings AM, Wong AT, Chirieac M, Montalban X.

Ther Adv Neurol Disord. 2023 Sep 21;16:17562864231194823.

Multiple SkleroseManagement & ScienceeHealth

2023

Schlieter H, Susky M, Richter P, Hickmann E, Scheplitz T, Burwitz B, Ziemssen T.

HMD 59, 1545–1563 (2022).

Multiple SkleroseMS Behandlung

2023

Jiang T, Ziemssen T, Wray S, Shen C, Söderbärg K, Lewin JB, Božin I, Freedman MS.

CNS Drugs. 2023 May;37(5):441-452.

Multiple SkleroseNeuroimmunologie

2023

Sotirchos ES, Hu C, Smith MD, Lord HN, DuVal AL, Arrambide G, Montalban X, Akgün K, Ziemssen T, Naismith RT, Hersh CM, Hyland M, Krupp LB, Nicholas JA, Bermel RA, Mowry EM, Calabresi PA, Fitzgerald KC.

Neurology. 2023 Oct 10:10.1212/WNL.0000000000207957.

Multiple SkleroseMS BehandlungNeuroimmunologie

2023

Proschmann U, Mueller-Enz M, Woopen C, Katoul Al Rahbani G, Haase R, Dillenseger A, Dunsche M, Atta Y, Ziemssen T, Akgün K.

Mult Scler. 2023 Sep 30:13524585231200719.